www.manusbio.comIndustrial / MaterialsFounded: 2011Funding to Date: $501.01MM
Manus Bio produces natural ingredients used in our daily lives as flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals and agricultural chemicals. Using its advanced fermentation technology, the company recreates natural processes for industrial biomanufacturing and provides sustainable and cost-effective sources of ingredients for health, wellness, and nutrition.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
04/14/2023 | Series C | $151.11MM | $xx.xx | $236.16MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
28,306,810
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
11/17/2020 | Series B-3 | $21.36MM | $xx.xx | $413.45MM | Almanack Family Office, Bbgi Public Company Limited, Mdi Ventures, Taihill Venture | |
Price per Share
$xx.xx
Shares Outstanding
400,763
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
3.1x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Almanack Family Office, Bbgi Public Company Limited, Mdi Ventures, Taihill Venture
|
||||||
11/17/2020 | Series B-2 | $3.03MM | $xx.xx | $413.45MM | Almanack Family Office, Bbgi Public Company Limited, Mdi Ventures, Taihill Venture | |
Price per Share
$xx.xx
Shares Outstanding
50,209
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
3.2x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Almanack Family Office, Bbgi Public Company Limited, Mdi Ventures, Taihill Venture
|
||||||
11/17/2020 | Series B-1 | $50.61MM | $xx.xx | $413.45MM | Almanack Family Office, Bbgi Public Company Limited, Mdi Ventures, Taihill Venture | |
Price per Share
$xx.xx
Shares Outstanding
712,061
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
3.3x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Almanack Family Office, Bbgi Public Company Limited, Mdi Ventures, Taihill Venture
|
||||||
07/03/2018 | Series A | $9.4MM | $xx.xx | $86.32MM | 415, Nxt Ventures | |
Price per Share
$xx.xx
Shares Outstanding
682,669
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.9x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
415, Nxt Ventures
|
||||||
07/03/2018 | Series A-1 | $11.59MM | $xx.xx | $86.32MM | 415, Nxt Ventures | |
Price per Share
$xx.xx
Shares Outstanding
701,696
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
2.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
415, Nxt Ventures
|
||||||
10/12/2016 | Series Seed-1 | $409,175.00 | $xx.xx | $6.86MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
88,951
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.3x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/12/2016 | Series Seed-2 | $3MM | $xx.xx | $6.86MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
616,765
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|